Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine viral diarrhoea virus bega strain - unknown - bovine viral diarrhoea virus bega strain vaccine-viral active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine viral diarrhoea virus trangie strain - unknown - bovine viral diarrhoea virus trangie strain biological-virus active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - modified live bovine viral diarrhoea virus type 1, non-cytopathic parent strain ke-9 and modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain ny-93 - immunologicals for bovidae, live viral vaccines - for active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (bvdv-1 and bvdv-2), and to reduce virus shedding and viraemia caused by bvdv-2.for active immunisation of cattle against bvdv-1 and bvdv-2, to prevent the birth of persistently infected calves caused by transplacental infection.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - bovine viral diarrhoea virus (inactivated) - bovine viral diarrhoea virus (inactivated) 0 vaccine - vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - bovine viral diarrhoea virus (bvd), strain 5960, killed - emulsion for injection - bovine - immunological - inactivated vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - pigs - for active immunisation of pigs from 7 weeks of age onwards to prevent mortality and reduce infection and disease caused by classical swine fever virus (csfv).onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv.onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - bovine parainfluenza 3 virus (pi3), rlb103, attenuated bovine respiratory syncytial virus (brsv), strain 375 attenuated bovine viral diarrhoea virus (bvd), strain 5960, killed bovine viral diarrhoea virus (bvd), strain 6309, killed - lyophilisate for suspension for injection - bovine - immunological - mixed vaccine (live and inactivated)

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis animal vaccines ltd - bovine viral diarrhoea (bvd) virus strain ky1203nc (inactivated): - suspension for injection - unknown - bovine viral diarrhea vaccine (bvd) - bovine - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco europe ltd - bovine viral diarrhoea (bvd) virus strain ky1203nc (inactivated): - suspension for injection - bovine viral diarrhea vaccine (bvd) - bovine - immunological - inactivated vaccine

New Zealand - English - Ministry for Primary Industries

hipra new zealand limited - bovine viral diarrhoea virus (inactivated); parainfluenza-3 virus (inactivated); infectious bovine rhinotrocheitis virus (inactivated) - bovine viral diarrhoea virus (inactivated) 0 vaccine; parainfluenza-3 virus (inactivated) 0 vaccine; infectious bovine rhinotrocheitis virus (inactivated) 0 vaccine - vaccine